These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 17618437)
1. New T cell epitopes identified from an anti-idiotypic antibody mimicking ovarian cancer associated antigen. Li W; Cui H; Meng FQ; Chang XH; Zhang G; Liu B; Li ZH Cancer Immunol Immunother; 2008 Feb; 57(2):143-54. PubMed ID: 17618437 [TBL] [Abstract][Full Text] [Related]
2. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody]. Li W; Cui H; Chang XH; Cheng HY; Cheng YX; Feng J; Fu TY Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):764-9. PubMed ID: 19087545 [TBL] [Abstract][Full Text] [Related]
3. [Induction of T cell responses against autologous ovarian cancer by anti-idiotype minibody-pulsed dendritic cells]. Yang WL; Cui H; Feng J; Chang XH; Fu TY; Ye X; Zhang H; Li XP; Wen HW; Feng LM; Tong CR Ai Zheng; 2004 Dec; 23(12):1639-45. PubMed ID: 15601552 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effects of T cells induced by fusion protein 6B11-pulsed dendritic cells on ovarian carcinoma cells. Yang W; Feng J; Chang X; Fu T; Ye X; Zhang H; Li X; Wen H; Feng L; Tong C; Cui H Gynecol Oncol; 2007 Apr; 105(1):238-43. PubMed ID: 17383546 [TBL] [Abstract][Full Text] [Related]
5. [In vivo study of antitumor immune responses induced by anti-idiotypic minibody vaccine of ovarian cancer]. Chang XH; Cui H; Feng J; Yang WL; Li Y; Fu TY Ai Zheng; 2004 Jul; 23(7):777-81. PubMed ID: 15248911 [TBL] [Abstract][Full Text] [Related]
6. [Antigen mimicry of anti-idiotypic antibodies for human ovarian carcinoma antigen: generation and characterization of anti anti-idiotype antibodies]. Lu WY; Qian HN Zhonghua Yi Xue Za Zhi; 1993 Oct; 73(10):581-3, 636. PubMed ID: 7508814 [TBL] [Abstract][Full Text] [Related]
7. [Specific immune cell therapy against ovarian cancer in vivo and in vitro]. Chang XH; Cheng HY; Cheng YX; Ye X; Guo HF; Fu TY; Zhang L; Zhang G; Cui H Ai Zheng; 2008 Dec; 27(12):1244-50. PubMed ID: 19079987 [TBL] [Abstract][Full Text] [Related]
8. [In vitro study of the antitumor immune responses induced by anti-idiotypic minibody vaccine of ovarian cancer]. Chang XH; Cui H; Feng J; Yang WL; Li Y; Fu TY; Ye X; Zhu HL; Cheng HY; Cheng YX; Guo HF Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):480-4. PubMed ID: 16224517 [TBL] [Abstract][Full Text] [Related]
9. Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine. Ohtake J; Ohkuri T; Togashi Y; Kitamura H; Okuno K; Nishimura T Immunol Lett; 2014 Sep; 161(1):20-30. PubMed ID: 24794408 [TBL] [Abstract][Full Text] [Related]
10. [The induction of specific immunity to human ovarian carcinoma cells by anti-idiotypic antibodies]. Lu WY; Qian HN; Li WJ Zhonghua Fu Chan Ke Za Zhi; 1994 Jan; 29(1):27-9, 60-1. PubMed ID: 8033621 [TBL] [Abstract][Full Text] [Related]
11. Antibodies designed as effective cancer vaccines. Metheringham RL; Pudney VA; Gunn B; Towey M; Spendlove I; Durrant LG MAbs; 2009; 1(1):71-85. PubMed ID: 20046577 [TBL] [Abstract][Full Text] [Related]
12. Construction, expression, and function of 6B11ScFv-mIL-12, a fusion protein that attacks human ovarian carcinoma. Cheng H; Ye X; Chang X; Ma R; Cong X; Niu Y; Zhang M; Liu K; Cui H; Sang J Med Oncol; 2015 Apr; 32(4):130. PubMed ID: 25794492 [TBL] [Abstract][Full Text] [Related]
13. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine. Maruyama H; Zaloudik J; Li W; Sperlagh M; Koido T; Somasundaram R; Scheck S; Prewett M; Herlyn D Cancer Immunol Immunother; 2000 Jun; 49(3):123-32. PubMed ID: 10881691 [TBL] [Abstract][Full Text] [Related]
14. [Preparation and characterization of monoclonal anti-anti-idiotypic antibody (3D12) of epithelial ovarian carcinoma]. Zhang C; Cui H; Li Xp; Ye X; Fu Ty; Feng J; Chang Xh; Wei LH Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 40(2):170-3. PubMed ID: 18458693 [TBL] [Abstract][Full Text] [Related]
15. A therapeutic human anti-idiotypic antibody mimics CD55 in three distinct regions. Spendlove L; Li L; Potter V; Christiansen D; Loveland BE; Durrant LG Eur J Immunol; 2000 Oct; 30(10):2944-53. PubMed ID: 11069077 [TBL] [Abstract][Full Text] [Related]
16. Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1. Matsuzaki J; Qian F; Luescher I; Lele S; Ritter G; Shrikant PA; Gnjatic S; Old LJ; Odunsi K Cancer Immunol Immunother; 2008 Aug; 57(8):1185-95. PubMed ID: 18253733 [TBL] [Abstract][Full Text] [Related]
17. 105Ad7 cancer vaccine stimulates anti-tumour helper and cytotoxic T-cell responses in colorectal cancer patients but repeated immunisations are required to maintain these responses. Durrant LG; Buckley DJ; Robins RA; Spendlove I Int J Cancer; 2000 Jan; 85(1):87-92. PubMed ID: 10585589 [TBL] [Abstract][Full Text] [Related]
18. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells. Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465 [TBL] [Abstract][Full Text] [Related]
20. The anti-tumor immune responses induced by a fusion protein of ovarian carcinoma anti-idiotypic antibody 6B11ScFv and murine GM-CSF in BALB/c mice. Cui H; Chang XH; Liu B; Feng J; Li Y; Ye X; Cao SJ; Fu TY; Yao Y; Li HQ; Qian HN Int J Gynecol Cancer; 2004; 14(2):234-41. PubMed ID: 15086722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]